All sponsors

Longbio Pharma

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-31
RECRUITING1
READOUTS ≤12 MONTHS1
Open Longbio Pharma on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
LP-003
NCT07291284
P3Active, not recruitingSeasonal Allergic Rhinitis5462026-03-31
LP-005 Injection
NCT07212426
P2Active, not recruitingPNH - Paroxysmal Nocturnal Hemoglobinuria302026-05-06
LP-003 Dose 1 (Single)
NCT07148557
P1/2Active, not recruitingAllergic Diseases62026-05-31
LP-003 Injection
NCT07313917
P2Not yet recruitingChronic Rhinosinusitis With Nasal Polyps (CRSwNP)1502027-02-28
LP-003 Injection
NCT07342803
P2RecruitingAllergic Asthma2002027-12-28
LP-005 Injection
NCT07266155
P2Not yet recruitingParoxysmal Nocturnal Hemoglobinuria302027-12-30
LP-005 Injection
NCT07363265
P2Not yet recruitingComplement-mediated Renal Diseases462028-08-02